Clinical Trial Detail

NCT ID NCT01661972
Title Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors John Strickler, M.D.
Indications

colorectal cancer

Advanced Solid Tumor

Therapies

Aflibercept + Capecitabine

Age Groups: adult

No variant requirements are available.